T1	Participants 47 159	patients with metastatic renal cell carcinoma previously treated with a tyrosine kinase inhibitor and everolimus
T2	Participants 161 226	Experience of 36 patients treated in France in the RECORD-1 Trial
T3	Participants 649 777	Data were reviewed for patients enrolled in RECORD-1 (Renal Cell Cancer Treatment With Oral RAD001 Given Daily) at French sites.
